Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: a case report

By Vitiello F.  

Targeted Oncology, Vol. 3, Iss. 4, 2008-10 ,pp. : 253-258

Springer Publishing Company

Access to resources Recommend Favorite

Extended Preoperative Chemotherapy Does Not Improve Pathologic Response and Increases Postoperative Liver Insufficiency After Hepatic Resection for Colorectal Liver Metastases

By Kishi Yoji  

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 2870-2876

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab Treatment Before Resection of Colorectal Liver Metastases: Safety, Recovery of Liver Function, Pathologic Assesment

By Dede K.  

Pathology & Oncology Research, Vol. 19, Iss. 3, 2013-07 ,pp. : 501-508

Springer Publishing Company

Access to resources Recommend Favorite

Predictive Factors for Hypertrophy of the Future Remnant Liver After Selective Portal Vein Embolization

By Baere Thierry   Teriitehau Christophe   Deschamps Frederic   Catherine Laurence   Rao Pramod   Hakime Antoine   Auperin Anne   Goere Diane   Elias Dominique   Hechelhammer Lukas  

Annals of Surgical Oncology, Vol. 17, Iss. 8, 2010-08 ,pp. : 2081-2089

Springer Publishing Company

Access to resources Recommend Favorite

Pathological complete response of colorectal liver metastases following chemotherapy with S-1 and oxaliplatin (SOX) in combination with bevacizumab: A case report

By                      

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 201-205

Spandidos Publications

Access to resources Recommend Favorite